Please assess the completion status of the following clinical trial:

Trial Title: Management of Signs and Symptoms Associated With Dry Eye Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with moderate dry eye defined as corneal fluorescein staining score of ≥ 3~* Age ≥ 18 years~* Distance best corrected visual acuity better than 20/60 Snellen equivalent in each eye~* Willing to sign a written informed consent to participate~* Able to follow study instructions, with the intention of completing all required visits~Exclusion Criteria:~* Presence of persistent corneal epithelial defect or ulcer in either eye~* Presence of active ocular infection in either eye~* Presence of ocular inflammation that is not related to keratoconjunctivitis sicca, e.g., allergy, severe blepharitis~* Presence of other corneal disorder(s) that give rise to reduced corneal sensitivity, such as recurrent herpes keratitis~* Presence of corneal diseases other than dry eye that can disturb the pre-corneal tear film such as epithelial basement membrane dystrophy (EBMD)~* Contact lens wear~* History of recent ocular surgery/trauma, which could affect corneal sensitivity, e.g., corneal transplantation, LASIK~* Presence of cicatricial ocular surface diseases~* A medical or ocular condition, or a personal situation, which in the principal investigator's opinion, is not appropriate for participation in the trial~* Any scheduled or planned ocular or systemic surgery or procedure during the study~* Pregnancy and women who are expecting to be pregnant.~* Current enrolment in another interventional drug or device study or participation in such a study within 30 days of anticipated entry into this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Arm (Type: EXPERIMENTAL): PROKERA SLIM + Standard of Care
- Control Arm (Type: ACTIVE_COMPARATOR): Standard of Care

Based on this trial design, predict the completion outcome and termination type (if applicable).